Skip to content

Educational purposes only — not medical advice. Consult your gastroenterologist before changing any regimen. Full disclaimer We may earn a commission on recommended products, at no extra cost to you. Disclosure

Mixed clinical results 2 studies reviewed · 2 sources

Boswellia serrata

Also known as: Indian frankincense · Salai guggal · H15 · Boswelan · AKBA

Indian frankincense resin that targets a distinctive inflammatory pathway and performed on par with mesalazine in an active-Crohn’s trial.

Mixed clinical results. Matched mesalazine in a randomised trial for active Crohn’s disease; a separate long-term maintenance study did not show an advantage over placebo. Exceptionally well tolerated in both.

Affiliate disclosure: We may earn a commission on recommended products, at no extra cost to you. Learn more

How it works

Boswellic acids — especially AKBA (acetyl-11-keto-β-boswellic acid) — are among the few natural compounds that directly inhibit 5-lipoxygenase, the enzyme that produces leukotriene B4. LTB4 is a powerful signal that draws inflammatory white cells into the gut lining, and it is found at high levels in inflamed IBD tissue. This is a pathway that neither steroids nor the major biologics address directly, which is why Boswellia is so interesting as a complement. Boswellic acids also help modulate NF-κB and human leukocyte elastase.

Traditional use

Known as salai guggal in Ayurveda, Boswellia resin has been used for thousands of years to support joint comfort, digestion and a balanced inflammatory response. Frankincense was traded along ancient routes across Arabia and India as both medicine and incense.

Highlights

  • In a 102-patient randomised trial, Boswellia extract H15 performed on par with mesalazine (the standard 5-ASA drug) for active Crohn’s.
  • Targets the 5-lipoxygenase / leukotriene pathway — a mechanism no approved Crohn’s drug addresses directly.
  • Outstanding tolerability in both clinical trials — one of the gentlest options in this guide.
  • A long-term maintenance study did not show a difference from placebo, so it may be best suited to periods of active support.
  • Look for extracts standardised to AKBA, the most active boswellic acid.

What the research shows

Every study below links to its original publication so you can read it yourself. Many natural compounds have only been studied in small trials. That isn’t a verdict on them; it reflects how little funding exists for compounds that can’t be patented.

Gerhardt 2001

Positive result

Randomised, double-blind, active-comparator non-inferiority trial · 102 randomised (83 per protocol) · Active Crohn’s disease

Boswellia extract H15 was not inferior to mesalazine on change in Crohn’s Disease Activity Index.

Holtmeier 2011

No significant difference

Randomised, double-blind, placebo-controlled maintenance trial across 22 German centres · 108 patients · Crohn’s disease in clinical remission

Terminated early for insufficient discrimination from placebo; good long-term tolerability but no maintenance benefit demonstrated.

Using it alongside conventional care

Boswellia stands out as the one botanical here tested head-to-head against a conventional Crohn’s medication: in the Gerhardt trial it was non-inferior to Mesalamine. Because it works on leukotrienes — a pathway that Humira, Remicade, Stelara, Skyrizi and Entyvio do not target directly — many people see it as a natural way to add a different kind of support rather than duplicate what their medication already does. Mention it to your care team if you take thiopurines such as Azathioprine, as Boswellia may influence how some drugs are metabolised.

Medications mentioned

Humira (adalimumab)

Anti-TNF biologic

Neutralises tumour necrosis factor alpha (TNF-α), a master cytokine driving intestinal inflammation.

Remicade (infliximab)

Anti-TNF biologic

Chimeric monoclonal antibody against TNF-α, delivered by infusion.

Prednisone (prednisone / prednisolone)

Corticosteroid

Broad transcriptional suppression of inflammatory gene programmes.

Mesalamine (mesalazine / 5-ASA)

Aminosalicylate

Topically acting anti-inflammatory at the mucosal surface.

Never stop or change a prescribed medication without your gastroenterologist. Many people use natural support alongside conventional care, and your care team can help you do that safely.

Recommended sourcing

Where to buy

What to look for in Boswellia serrata

  • Standardised boswellic acids — ideally with a stated AKBA percentage
  • Branded extracts (5-Loxin, AprèsFlex, Boswellin) have their own research
  • Third-party tested for purity and heavy metals
  • Gum resin extract, not whole-plant powder

Modern AKBA-enriched extracts are dosed much lower than the 1990s–2000s trial preparations, so follow the product’s own standardisation.

Shop trusted retailers

Paid links: we may earn a commission when you buy through these links, at no extra cost to you. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Amounts used in research

Gerhardt used H15 at 3.6 g/day. Holtmeier used Boswelan 400 mg capsules, 2 capsules three times daily (2.4 g/day) for 52 weeks. Modern AKBA-enriched extracts are dosed far lower and are not interchangeable with either.

Good to know

  • Among the best-tolerated agents in this category across both trials.
  • Occasional mild GI upset, nausea or reflux.
  • May inhibit CYP3A4 and P-glycoprotein in vitro — relevant alongside thiopurines and other narrow-therapeutic-index drugs.
  • Rare reports of allergic skin reactions.

Community experiences

Reported benefit

Typical dose

Time to notice

Common pairings

Real-world data for Boswellia serrata is coming. When our Community Symptom Tracker launches, this section will show anonymised, aggregated experiences from people with Crohn’s who have tried Boswellia serrata: how many noticed a difference, what they took, and what they paired it with.

Community data will always be labelled as self-reported, and it won’t replace the published research above.

Coming soon

Tried Boswellia serrata? Your experience matters.

Our Community Symptom Tracker will let you log what you take and how you feel — and see what’s working for people like you. Alongside it, our wellness store will offer curated, third-party-tested protocols.

Learn about the tracker Store launching soon

Sources

  1. Therapy of active Crohn disease with Boswellia serrata extract H 15

    Gerhardt H, Seifert F, Buvari P, Vogelsang H, Repges R. · Zeitschrift für Gastroenterologie · 2001 · PMID 11215357

Phase 2 — in development

Where traditional research stops, our community begins

Natural compounds can’t be patented, so they rarely get the multi-million-dollar trials that drugs receive. That leaves people with Crohn’s without answers to the questions that matter most: what actually helps, at what dose, and for whom? Our Community Symptom Tracker will crowdsource those answers from real people living with Crohn’s, and our upcoming wellness store will make it easy to find quality, third-party-tested products.

  • Log your symptoms, supplements and doses in a private daily tracker
  • See what’s working for people with the same disease location and medications
  • Contribute to the largest real-world dataset on natural Crohn’s support
  • Shop curated, third-party-tested protocols from our upcoming store

Be one of the first to join

Early access is opening soon. Bookmark this page and check back — we’ll announce sign-ups here first.

Early access opening soon Read our mission